iCARDIO Alliance global implementation guidelines on heart failure 2025
2025年iCARDIO联盟全球心力衰竭管理实施指南
摘要
This document is about heart failure(HF),including acute and chronic heart failure,heart failure with reduced ejection fraction and heart failure with preserved ejection fraction as well as cardiomyopathies.Context-specific recommendations tailored to individual patient needs are highlighted providing a thorough evaluation of the risks,benefits,and overall value of each therapy,aiming to establish a standard of care that improves patient outcomes and reduces the burden of hospitalization in this susceptible population.These guidelines provide evidence-based recommendations that represent a group consensus considering many other published guidelines that have reviewed many of the issues discussed here,but they also make new recommendations where new evidence has recently emerged.Most importantly these guidelines also provide recommendations on a number of issues where resource limitations may put constraints on the care provided to HF patients.Such"economic adjustment"recommendations aim to provide guidance for situations when"Resources are somewhat limited"or when"Resources are severely limited".Hence,this document presents not only a comprehensive but also concise update to HF management guidelines thereby aiming to provide a unified strategy for the pharmacological,non-pharmacological,invasive and interventional management of this significant global health challenge that is applicable to the needs of healthcare around the globe.
本指南涵盖急慢性心力衰竭、射血分数降低的与射血分数保留的心力衰竭以及心肌病的诊疗,并根据患者个体化需求提出分层建议,权衡每种治疗方式的风险、获益及成本效益,以降低住院负担并改善预后。本指南基于既往已发表指南及共识,同时涵盖了近期更新的临床证据,特别针对资源有限地区(“资源部分受限”或“资源严重受限”)提出适应性调整方案。本指南内容涵盖心力衰竭的预防、诊断、药物治疗、器械治疗、手术/介入治疗及合并症管理。此外,本指南强调多学科协作、患者教育及个性化治疗的重要性,以应对不同医疗环境下的实践挑战。
出处
《中华心力衰竭和心肌病杂志(中英文)》
2025年第3期179-206,共28页
Chinese Journal of Heart Failure and Cardiomyopathy
参考文献1
-
1国家心血管病中心,国家心血管病专家委员会心力衰竭专业委员会,中国医师协会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会,张健,张宇辉,黄峻,张抒扬,王现强,周蕾.国家心力衰竭指南2023[J].中华心力衰竭和心肌病杂志(中英文),2023,7(4):215-311. 被引量:158
二级参考文献35
-
1无,唐建军,陈雅琴,周胜华,高传玉,杨伟宪,张宇辉.经皮机械循环辅助临床应用及管理中国专家共识[J].中华心力衰竭和心肌病杂志(中英文),2020,4(3):145-158. 被引量:25
-
2无,李殿富,刘燕荣,张健,张宇辉.围生期心肌病诊断和治疗中国专家共识2021[J].中华心力衰竭和心肌病杂志(中英文),2021,5(1):3-16. 被引量:14
-
3中国医师协会心力衰竭专业委员会,国家心血管病专家委员会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会,张健,张宇辉,许顶立,宋昱,韩凌,黄燕,翟玫,王运红.中国心力衰竭患者离子管理专家共识[J].中华心力衰竭和心肌病杂志(中英文),2020,4(1):16-31. 被引量:119
-
4黄峻.心力衰竭“易损期”及其心率管理的新认识新理念[J].中华心力衰竭和心肌病杂志(中英文),2018,2(2):111-113. 被引量:14
-
5托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
-
6中国医师协会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会,张宇辉,许顶立,白玲.心力衰竭容量管理中国专家建议[J].中华心力衰竭和心肌病杂志(中英文),2018,2(1):8-16. 被引量:192
-
7中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:1005
-
8无.β肾上腺素能受体阻滞剂在心血管疾病应用专家共识[J].中华心血管病杂志,2009,37(3):195-209. 被引量:201
-
9无.心肌病磁共振成像临床应用中国专家共识[J].中华心血管病杂志,2015,43(8):673-681. 被引量:36
-
10张健,邹长虹,黄燕,周琼,张宇辉,吕蓉.扩张型心肌病住院患者左心室收缩功能障碍恢复和复发的发生率及其预测因素[J].中华心血管病杂志,2015,43(12):1034-1039. 被引量:13
共引文献157
-
1贾婉玉,全雪丽,宋春兰,王洁,成怡冰.ECMO辅助儿童休克治疗的临床评价[J].实用休克杂志(中英文),2024,8(3):142-147.
-
2湖北省心血管内科医疗质量控制中心,武汉医学会心血管病学分会心衰学组,湖北省医师协会心血管内科医师分会,湖北省医学生物免疫学会心血管免疫专委会,湖北省心衰中心联盟,袁璟,廖梦阳,程翔,廖玉华.心力衰竭常见病因及合并症的基层处理专家建议[J].临床心血管病杂志,2024,40(3):161-166. 被引量:4
-
3黄峻.构建中国特色心力衰竭现代管理的宏图大略—《国家心力衰竭指南2023》介绍和述评[J].中华心力衰竭和心肌病杂志(中英文),2023,7(4):209-214. 被引量:1
-
4史凯蕾.重视老年心力衰竭患者合并营养不良[J].老年医学与保健,2024,30(2):277-280. 被引量:1
-
5何紫勋,侯雅竹,张妍,郑颖,王帅,闫玲燕,任晓宇,王贤良,毛静远.慢性心力衰竭病人6 min步行试验与代谢当量的相关性[J].中西医结合心脑血管病杂志,2024,22(9):1647-1650. 被引量:8
-
6杨莹,傅国胜.《国家心力衰竭指南2023》解读[J].心脑血管病防治,2024,24(4):1-5. 被引量:6
-
7杨海燕,刘英,曹艳华,黄燕红.老年心力衰竭合并肺部感染患者病原菌分布及血清IL-8、PTX3水平变化[J].中国病原生物学杂志,2024,19(6):724-728. 被引量:9
-
8刘会若,宋毅,张艳,张姗,马丹珂,吴婷,郑璐.二维斑点追踪超声心动图评估慢性心力衰竭患者左心房心肌力学变化[J].中华实用诊断与治疗杂志,2024,38(6):623-628. 被引量:7
-
9张健.关山初度尘未洗策马扬鞭再奋蹄[J].中华心力衰竭和心肌病杂志(中英文),2024,8(1):1-1.
-
10齐晨,关敬元,王锦溪,周萍,翟玫,周琼,张健.不同血清尿酸水平对心力衰竭患者的预后价值[J].中华心力衰竭和心肌病杂志(中英文),2024,8(1):2-9. 被引量:2
-
1Xi Jia,Xiaorui Xiang,Jinghui Li,Kai Yang,Shujuan Yang,Jiaxin Wang,Yanyan Song,Zhixiang Dong,Yun Tang,Shihua Zhao.The Re-Diagnostic Value of Cardiac Magnetic Resonance for Cardiovascular Diseases[J].Cardiology Discovery,2025,5(2):182-184.
-
2王军.重组人脑利钠肽联合沙库巴曲缬沙坦治疗高血压病伴急性心力衰竭患者的疗效[J].基层医学论坛,2025,29(28):91-93.
-
3Yaru Qian,Deying Hu.A Study of Staged Differences in the Needs of Lymphoma Patients throughout the Service under the Care Perspective[J].Journal of Clinical and Nursing Research,2025,9(6):179-187.
-
4Siddikatou Djibrilla,Mandeng Ma Linwa Edgar,Ndom Marie Solange,Nkoke Clovis,Mouliom Sidick,Ndobo Valérie,Tsague Hermann,Ndoumou Lok Xaviere Audrey,Njedock Sontsa Nelson Venceslas,Kamdem Félicité,Ba Hamadou.Trends and Predictors of In-Hospital Mortality among Heart Failure Patients in a Cameroonian Tertiary Care Center,2021-2024-Mortality Predictors in Acute Heart Failure in Cameroon[J].World Journal of Cardiovascular Diseases,2025,15(7):357-373.
-
5Takahiko Nagamine.Gut-skin-brain axis in people suffering from sepsis with acute skin failure[J].World Journal of Psychiatry,2025,15(7):5-10.
-
6Kaijing Chen,Fengying Wei,Xinyan Zhang,Hao Jin,Ruiyang Zhou,Yue Zuo,Kai Fan.Dynamics of an SVEIR transmission model with protection awareness and two strains[J].Infectious Disease Modelling,2025,10(1):207-228.
-
7Hui Chen,Haibo Qiu.Acute respiratory distress syndrome:Rethinking and research priorities[J].Chinese Medical Journal,2025,138(13):1516-1518.
-
8Lin-Lin Wang,Yong-Hong Fan.Global stability analysis of an epidemic model with feedback control and general incidence rate[J].International Journal of Biomathematics,2025,18(4):289-331.
-
9Wei Chen,Peng Li.Ultrasound-controlled HOFs:a breakthrough in precision drug delivery[J].Science China Materials,2025,68(6):2152-2153.
-
10洪世英,葛巧宾,徐弘扬.基于自进化学习算法的急性心力衰竭患者院内MACE风险预测研究[J].新疆医科大学学报,2025,48(10):1400-1405.